首页> 外国专利> METHOD OF TREATING CHRONIC RECURRENT ORAL ULCERATION

METHOD OF TREATING CHRONIC RECURRENT ORAL ULCERATION

机译:治疗慢性复发性口腔溃疡的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to dentistry, and can be used for treating chronic recurrent oral ulceration. Method of treating chronic recurrent oral ulceration includes clinical and biochemical examination of the patient and prescribing the drug therapy, meaning reception of sublingual tablets of sodium aminodihydro-phthalazinedione (Galavit) as per 10 days by 4 tablets and 10 days every second day in a daily dose. Additionally, presence of urogenital infection is detected using real-time polymerase chain reaction and immunological parameters of the oral fluid are examined and if the patient's urogenital infection is identified and values of local immunity factors balance coefficient exceed 4.59±0.343 and secretory immunoglobulin A concentration lower than 0.089±0.012 prescribed are the sublingual pills based on sodium aminodihydro-phthalazinedione (Galavit) for 30 days according to the schedule: 10 days - daily - 4 tablets a day, further - 10 days taking pills every second day in the same daily dose, hydroxyzine hydrochloride (Atarax) in 3 receptions by 12.5 mg in the morning and the afternoon, 25 mg in the evening for 4 weeks and intraoral applications with lanthanum triethylene trinitrate in polyhydroxy compounds (Eplan) with the duration of 20-30 minutes 3-4 times a day till complete epithelization of the injury elements.;EFFECT: using the invention enables reducing the treatment terms, reducing the epithelization terms, reducing the pain syndrome and the rate of recurrences.;1 cl, 2 tbl, 2 ex
机译:技术领域:药物:发明是指药物,即牙科,并且可以用于治疗慢性复发性口腔溃疡。治疗慢性复发性口腔溃疡的方法包括对患者进行临床和生化检查并开出药物治疗处方,这意味着每天每10天接受4片氨基丁二氢邻苯二甲酮二钠(Galavit)的舌下片,每天第二天每10天接受一次剂量。此外,使用实时聚合酶链反应检测泌尿生殖道感染的存在,并检查口腔液的免疫学参数,是否识别出患者的泌尿生殖道感染且局部免疫因子平衡系数的值超过4.59±0.343且分泌性免疫球蛋白A的浓度更低超过0.089±0.012的是根据时间表按氨基二氢邻苯二甲酮二钠(Galavit)配制的舌下药丸,持续30天:10天-每天-每天4片,此外-每两天以相同的日剂量服用10天,盐酸羟嗪(Atarax)在3次接收中,上午和下午分别为12.5 mg,晚上25 mg,持续4周,以及在多羟基化合物中使用三硝酸三镧镧(Eplan)进行口服应用,持续时间20-30分钟3每天4次,直到损伤成分完全上皮。效果:使用本发明可以减少治疗时间,减少上皮化术语,减少疼痛综合征和复发率。; 1 cl,2 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号